Publications













Visit Elsevier's
Caring for the Ages Web Site
Get Your Free Subscription! Selected Articles 2001-2004

Caring for the Ages
Selected Articles from
April 2003;
Vol. 4, No. 4
Implementing AMDA's Falls & Fall Risk CPG in the Clinical Setting
A Systematic, Evidence-Based Approach to Managing Challenging Behavior in Nursing Homes
Clinical AbstractScan
Pain in the Elderly: Listen to the Patient's Voice
A Daughter's Journal: During a Visit, "the Play's the Thing"
Reducing Medication Errors in Nursing Homes
Elders Urged to "Dance to Your Heart's Content"
Previous Month's Articles
Following Month's Articles

Pain in the Elderly: Listen to the Patient's Voice

by Gretchen Henkel

SAN DIEGO--Pain research has burgeoned in the last three decades, producing advancements in genetics and molecular biology to better explain pain genesis, and yielding more sophisticated treatments for acute, chronic, and terminal cancer pain. But there's still work to be done if clinicians are to successfully address and treat elderly patients' pain, agreed researchers and workshop presenters at the recent 10th World Congress on Pain, hosted here by the International Association for the Study of Pain (IASP).

North American research suggests that pain is still undertreated in older adults, including those in institutional settings, according to M. Gail Woodbury, PhD, Adjunct Professor in the Department of Epidemiology and Biostatistics at the University of Western Ontario in London, Canada." The literature identifies the need for more descriptive, self-report, and longitudinal research to direct efforts to improve delivery of pain services to this population," she noted recently from her office in Canada.

Accordingly, Woodbury's colleagues Maggie Gibson, PhD, a psychologist and researcher with the Veterans Care Program at St. Joseph's Health Care in London, Ontario, designed a clinical study to assess self-reported pain over time in a sample of elderly Canadian war veterans living in a chronic care facility. Among the conclusions, which Dr. Gibson presented during a poster session at the World Congress, is that the first step toward optimum pain management in the elderly depends upon appropriate and comprehensive assessment. Slightly over half of the 33 war veterans participating in the study reported having pain at regular follow-up assessments, which occurred at quarterly intervals over a two-year time frame. In most instances, reported Dr. Gibson, patients' pain "predated their admission to the facility," reflecting the high prevalence of chronic pain conditions such as arthritis in the elderly.

The results of their study, which was funded by a research grant from the Parkwood Hospital Foundation in London, Ontario, underscore the complexities of diagnosing and treating pain in the heterogeneous elderly population. For example, although the patients in this study did not exhibit significant levels of cognitive impairment, many found it difficult to describe pain quality, while others described combined patterns of "dull, aching, throbbing" or "sharp, shooting, burning" pains.

Multiple Assessments

Inclusion criteria for the St. Joseph's Health Care facility study were straightforward: participants needed to be able and willing to consent to participation, and to be admitted to the facility from September, 1998 through October, 1999. More than half (57%) of newly admitted residents met inclusion criteria, and 59% of the eligible residents agreed to participate. They were then followed for a two-year period, or until discharge from the facility or death.

Multiple Measures Assess Pain, Function,
& Quality of Life
In the study conducted at St. Joseph's Health Care in London, Ontario, Canada, researchers used the following measures to assess patients' pain, pain beliefs, and the impact of pain on their lives:
Pain Beliefs Questionnaire (PBQ): 12 items that the patient rates from 1-6, with higher numbers indicating greater agreement, yielding subscale scores for Organic (O) and Psychological (P) beliefs regarding pain etiology and control.
Geriatric Depression Scale (GDS): 30 items answered yes/no; scores of 11-30 suggest depression.
Standardized Mini-Mental Status Examination (SMMSE): 20 questions totaling 30 points. The normal range is 24-30; mild cognitive impairment is 20-23; moderate impairment is 10-19; and severe is a score of 0 to 9.
Anxiety Measure (ANX): Consists of one question: "Do you worry about your health?" yes/no
Delighted- Terrible Quality-of-Life Scale (D-T): Patient is given the choice of 7 possible responses, ranging from "terrible" (1) to "delighted" (7), in answer to the question, "Which of these best describes how you feel about your life?"
Comprehensive Pain Assessment (CPA): Questions are designed to assess the onset, type, description, intensity, duration, exacerbation, variability, expression and impact of the patient's pain.
Source: Description of measures provided by M. Gail Woodbury, PhD, and Maggie Gibson, PhD

At admission, enrolled participants verbally completed a structured interview conducted by a research assistant. The interview included five measures: Pain Beliefs Questionnaire, Geriatric Depression Scale, Standardized Mini-Mental Status Examination, Anxiety Measure, and Delighted-Terrible Quality-of-Life Scale (see box at right). Patients who reported having pain also completed the Comprehensive Pain Assessment.

At each subsequent assessment, patients were again queried about their pain, its impact, and the types of pain-relief methods used for treatment. For most of the patients reporting pain, the researchers found, onset had occurred during older adulthood, and was mostly somatic (as opposed to neuropathic) in origin.

Patients reported expressing their pain in several forms, including verbalizations, nonverbal vocalizations (e.g., moaning), behaviors (e.g., grimacing), and requests for medications. At least 60% and sometimes as many as 100% (depending on which three-month interval) of those in pain reported that they experienced physical limitations due to their pain. Patients' pain intensity was often exacerbated by either motor activity or restriction of activity.

Patients identified a variety of pain-control methods that they used to manage their pain, including pharmacologic as well as non-pharmacologic approaches. The interdisciplinary staff of the Veterans Care Program develops care plans in collaboration with patients, explained Dr. Gibson . "In this observational study, patients themselves identified high usage of both pharmacological and non-pharmacological interventions, which provides indirect support that pain was commonly recognized as a clinical concern by staff in this setting."

Patient-Centered Approach

The assessments performed for the purposes of this study are in alignment with best-practice recommendations included in the clinical practice guidelines (CPGs) for pain management in older persons formulated by the American Geriatrics Society and published last June in the Journal of the American Geriatrics Society (2002;50:S205-S224). During an educational workshop at the World Congress entitled "Recent Developments in the Study, Treatment, and Assessment of Pain in Older Persons," presenter Bruce A. Ferrell, MD, a Professor in the Division of Geriatrics, UCLA Medical School, and Chairman of the AGS' CPG committee, highlighted the problem of undertreatment of pain in the elderly." The literature," he noted, "is replete with examples of sub-populations of elderly people who tend to have poor pain management. Both observational studies and epidemiological studies suggest that older patients with cancer pain receive poorer care than patients who are younger with cancer pain." The same holds true, said Dr. Ferrell, for postoperative pain management in older people.

The AGS guidelines, an update of the 1998 version, recommend that all patients coming into a facility be screened for the presence of chronic or persistent pain. For patients who are cognitively intact, as were the patients participating in the St. Joseph Health Care study, the panel found that research supports the use of direct inquiry.

Interestingly, the AGS panel's literature search revealed, said Dr. Ferrell, that "elderly people often don't like to use the word 'pain.' They like to use other words. They describe [the pain sensation] as a discomfort, or a soreness, or an aching." If clinicians do not use similar words, he said, they may not discover their patients' real pain problems.

Comprehensive, individualized pain assessment, maintain Drs. Woodbury and Gibson, will most likely contribute to improvements in pain management for older adults in institutions. "In essence," said Dr. Gibson, "what we are advocating is a 'patient-centered' approach to pain management." Further research is now planned in collaboration with other Veterans Care facilities across Canada through the VET-LINK research network that Dr. Gibson is spearheading.

Genetic Variant Influences Pain Response

A common genetic variant influences individual responses and adaptation to pain and other stressful stimuli, and may underlie vulnerability to many psychiatric and other complex diseases, reported David Goldman, MD, Chief, Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, and colleagues at NIAAA and the University of Michigan. The study, COMT val 158 met Genotype Affects mµ-Opioid Neurotransmitter Responses to a Pain Stressor, was published in the February 21 issue of the journal Science (2003;299:1240).

"Emotional response to stress contributes in many drinkers to the development of alcoholism," said George Kunos, MD, PhD, Scientific Director of the Division of Intramural Clinical and Biological Research at NIAAA." Dr. Goldman and his colleagues have uncovered a genetic explanation for why some individuals and groups may be especially susceptible to consuming alcohol and to increasing their consumption in response to stress."

Earlier reports by first author Jon-Kar Zubieta, MD, PhD, of the Department of Psychiatry and Mental Health Research Institute and Department of Radiology at the University of Michigan and others showed that responses to pain vary considerably from one person to another, with some of the difference in sensitivity attributable to genetic factors (Science 2001;293:311). Subsequent work showed that some of these effects were due to gender-related factors (Journal of Neuroscience 2002;22:5100).

For the current study, Drs. Goldman, Zubieta and their colleagues used positron emission tomography (PET), targeting the endogenous opioid system to examine the effects of a specific genetic variant on neurochemical brain responses to sustained pain. The researchers also used questionnaires that measure pain-related sensory and affective qualities and internal emotional state to link the neurochemical responses to participants' psychological and physical experience of the pain challenge.

The cathechol-'O'-methyltransferase (COMT) gene encodes a major enzyme involved in the metabolism of the neurotransmitters dopamine (a chemical messenger involved in motivation and reward) and norepinephrine (a chemical messenger involved in sympathetic nervous system stimulation and inhibition). The 'val 158 met' variant of the COMT gene codes the substitution of valine ('val') by methionine ('met') and is associated with a three-to-fourfold reduction in COMT enzyme activity. This is a common genetic variant such that the distribution of the three genotypes in the general population is approximately 1/3, 1/2, and 1/6, respectively. Previous research has linked 'val 158 met' genotypes to a number of behavioral diseases with complex origins, including obsessive-compulsive disease and schizophrenia.

Drs. Goldman, Zubieta, and colleagues hypothesized that variations in COMT activity conferred by the various val 158 met genotypes might influence functions regulated by dopamine and adrenergic/noradrenergic (epinephrine/norepinephrine) neurotransmission. One such system, the mµ-opioid neurotransmitter system, typically is activated in response to prolonged pain or stress.

To test their hypothesis, the researchers examined 15 men and 14 women genotyped with respect to the val 158 met polymorphism. The participants were randomized and blinded during the infusion of painful and non-painful saline solutions.

As anticipated, the researchers who monitored neurochemical changes observed significant effects of genotype on mµ-opioid receptor binding and system activation.

Compared with heterozygotes (individuals with one copy of each allele), individuals with two copies of the met 158 allele and lowest COMT enzyme activity showed diminished regional mµ-opioid system responses, higher sensory and affective ratings of pain, and a more negative internal state.

Persons with two copies of the val 158 allele and greater COMT enzyme activity demonstrated opposite effects. The regions of the brain showing these changes included the thalamus, a key pain sensory relay station in the pathway for pain perception, and the amygdala, a region of the brain integral for the emotions of anxiety and distress.

"These data emphasize the need for a systems-level approach to neurobiological processes whereby genetic variation, neuronal functional measures, and phenotypic traits [all physical qualities of the behaving organism] are fully integrated," the authors conclude.


This article originally appeared in Caring for the Ages, April 2003; Vol. 4 No. 4, p. 44-47. Caring for the Ages is an official publication of the American Medical Directors Association, published by Elsevier. This article may not be reproduced in any form, print or electronic, without permission.

The opinions expressed by the authors are their own
and not necessarily those of AMDA or of Elsevier.

back to top

Print Version     11000 Broken Land Parkway, Suite 400 Columbia, MD 21044
    Phone: 410-740-9743 • Toll free: 800-876-2632
    Fax: 410-740-4572 • E-mail: webmaster@amda.com